Sonia T Hegde1,2, Henrik Salje1,3, Hossain M S Sazzad4,5, M Jahangir Hossain4, Mahmudur Rahman6, Peter Daszak7, John D Klena8, Stuart T Nichol8, Stephen P Luby2,9, Emily S Gurley1,4. 1. Johns Hopkins University, Baltimore, Maryland, USA. 2. Global Disease Detection, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. 3. Institut Pasteur, Paris, France. 4. International Center for Diarrheal Disease Research, Bangladesh (ICDDR, B), Dhaka, Bangladesh. 5. University of New South Wales, Sydney, New South Wales, Australia. 6. Institute of Epidemiology Disease Control and Research, Dhaka, Bangladesh. 7. EcoHealth Alliance, New York, USA. 8. Viral Special Pathogens, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. 9. Stanford University, Palo Alto, California, USA.
Abstract
BACKGROUND: Understanding the true burden of emergent diseases is critical for assessing public-health impact. However, surveillance often relies on hospital systems that only capture a minority of cases. We use the example of Nipah-virus infection in Bangladesh, which has a high case-fatality ratio and frequent person-to-person transmission, to demonstrate how healthcare-seeking data can estimate true burden. METHODS: We fit logistic-regression models to data from a population-based, healthcare-seeking study of encephalitis cases to characterize the impact of distance and mortality on attending one of three surveillance hospital sites. The resulting estimates of detection probabilities, as a function of distance and outcome, are applied to all observed Nipah outbreaks between 2007 and 2014 to estimate the true burden. RESULTS: The probability of attending a surveillance hospital fell from 82% for people with fatal encephalitis living 10 km away from a surveillance hospital to 54% at 50 km away. The odds of attending a surveillance hospital are 3.2 (95% confidence interval: 1.6, 6.6) times greater for patients who eventually died (i.e. who were more severely ill) compared with those who survived. Using these probabilities, we estimated that 119 Nipah outbreaks (95% confidence interval: 103, 140)-an average of 15 outbreaks per Nipah season-occurred during 2007-14; 62 (52%) were detected. CONCLUSIONS: Our findings suggest hospital-based surveillance missed nearly half of all Nipah outbreaks. This analytical method allowed us to estimate the underlying burden of disease, which is important for emerging diseases where healthcare access may be limited.
BACKGROUND: Understanding the true burden of emergent diseases is critical for assessing public-health impact. However, surveillance often relies on hospital systems that only capture a minority of cases. We use the example of Nipah-virus infection in Bangladesh, which has a high case-fatality ratio and frequent person-to-person transmission, to demonstrate how healthcare-seeking data can estimate true burden. METHODS: We fit logistic-regression models to data from a population-based, healthcare-seeking study of encephalitis cases to characterize the impact of distance and mortality on attending one of three surveillance hospital sites. The resulting estimates of detection probabilities, as a function of distance and outcome, are applied to all observed Nipah outbreaks between 2007 and 2014 to estimate the true burden. RESULTS: The probability of attending a surveillance hospital fell from 82% for people with fatal encephalitis living 10 km away from a surveillance hospital to 54% at 50 km away. The odds of attending a surveillance hospital are 3.2 (95% confidence interval: 1.6, 6.6) times greater for patients who eventually died (i.e. who were more severely ill) compared with those who survived. Using these probabilities, we estimated that 119 Nipah outbreaks (95% confidence interval: 103, 140)-an average of 15 outbreaks per Nipah season-occurred during 2007-14; 62 (52%) were detected. CONCLUSIONS: Our findings suggest hospital-based surveillance missed nearly half of all Nipah outbreaks. This analytical method allowed us to estimate the underlying burden of disease, which is important for emerging diseases where healthcare access may be limited.
Authors: Sonia T Hegde; Hossain M S Sazzad; M Jahangir Hossain; Mahbub-Ul Alam; Eben Kenah; Peter Daszak; Pierre Rollin; Mahmudur Rahman; Stephen P Luby; Emily S Gurley Journal: Ecohealth Date: 2016-10-13 Impact factor: 3.184
Authors: Birgit Nikolay; Henrik Salje; Katharine Sturm-Ramirez; Eduardo Azziz-Baumgartner; Nusrat Homaira; Makhdum Ahmed; A Danielle Iuliano; Repon C Paul; Mahmudur Rahman; M Jahangir Hossain; Stephen P Luby; Simon Cauchemez; Emily S Gurley Journal: PLoS Med Date: 2017-01-17 Impact factor: 11.069
Authors: Kate E Jones; Nikkita G Patel; Marc A Levy; Adam Storeygard; Deborah Balk; John L Gittleman; Peter Daszak Journal: Nature Date: 2008-02-21 Impact factor: 49.962
Authors: Pritimoy Das; Hossain M S Sazzad; Mohammad Abdul Aleem; M Ziaur Rahman; Mahmudur Rahman; Simon J Anthony; W Ian Lipkin; Emily S Gurley; Stephen P Luby; John J Openshaw Journal: Philos Trans R Soc Lond B Biol Sci Date: 2019-08-12 Impact factor: 6.237
Authors: Enzo Tramontano; Bart Tarbet; Jessica R Spengler; Katherine Seley-Radtke; Chris Meier; Robert Jordan; Zlatko Janeba; Brian Gowen; Brian Gentry; José A Esté; Mike Bray; Graciela Andrei; Luis M Schang Journal: Antiviral Res Date: 2019-07-11 Impact factor: 5.970
Authors: Jonathan H Epstein; Simon J Anthony; Ariful Islam; A Marm Kilpatrick; Shahneaz Ali Khan; Maria D Balkey; Noam Ross; Ina Smith; Carlos Zambrana-Torrelio; Yun Tao; Ausraful Islam; Phenix Lan Quan; Kevin J Olival; M Salah Uddin Khan; Emily S Gurley; M Jahangir Hossein; Hume E Field; Mark D Fielder; Thomas Briese; Mahmudur Rahman; Christopher C Broder; Gary Crameri; Lin-Fa Wang; Stephen P Luby; W Ian Lipkin; Peter Daszak Journal: Proc Natl Acad Sci U S A Date: 2020-11-02 Impact factor: 11.205
Authors: Clifton D McKee; Ausraful Islam; Stephen P Luby; Henrik Salje; Peter J Hudson; Raina K Plowright; Emily S Gurley Journal: Viruses Date: 2021-01-23 Impact factor: 5.048
Authors: Manuel Ruiz-Aravena; Clifton McKee; Amandine Gamble; Tamika Lunn; Aaron Morris; Celine E Snedden; Claude Kwe Yinda; Julia R Port; David W Buchholz; Yao Yu Yeo; Christina Faust; Elinor Jax; Lauren Dee; Devin N Jones; Maureen K Kessler; Caylee Falvo; Daniel Crowley; Nita Bharti; Cara E Brook; Hector C Aguilar; Alison J Peel; Olivier Restif; Tony Schountz; Colin R Parrish; Emily S Gurley; James O Lloyd-Smith; Peter J Hudson; Vincent J Munster; Raina K Plowright Journal: Nat Rev Microbiol Date: 2021-11-19 Impact factor: 78.297
Authors: Sonia T Hegde; Elizabeth C Lee; Ashraful Islam Khan; Stephen A Lauer; Md Taufiqul Islam; Taufiqur Rahman Bhuiyan; Justin Lessler; Andrew S Azman; Firdausi Qadri; Emily S Gurley Journal: J Infect Dis Date: 2021-12-20 Impact factor: 5.226
Authors: Jennifer Cable; Anthony Fauci; William E Dowling; Stephan Günther; Dennis A Bente; Pragya Dhruv Yadav; Lawrence C Madoff; Lin-Fa Wang; Rahul K Arora; Maria Van Kerkhove; May C Chu; Thomas Jaenisch; Jonathan H Epstein; Simon David William Frost; Daniel G Bausch; Lisa E Hensley; Éric Bergeron; Ioannis Sitaras; Michael D Gunn; Thomas W Geisbert; César Muñoz-Fontela; Florian Krammer; Emmie de Wit; Pontus Nordenfelt; Erica Ollmann Saphire; Sarah C Gilbert; Kizzmekia S Corbett; Luis M Branco; Sylvain Baize; Neeltje van Doremalen; Marco A Krieger; Sue Ann Costa Clemens; Renske Hesselink; Dan Hartman Journal: Ann N Y Acad Sci Date: 2022-10-02 Impact factor: 6.499